These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25217292)
1. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study. Chouraki V; Beiser A; Younkin L; Preis SR; Weinstein G; Hansson O; Skoog I; Lambert JC; Au R; Launer L; Wolf PA; Younkin S; Seshadri S Alzheimers Dement; 2015 Mar; 11(3):249-57.e1. PubMed ID: 25217292 [TBL] [Abstract][Full Text] [Related]
2. Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome. Prasher VP; Sajith SG; Mehta P; Zigman WB; Schupf N Int J Geriatr Psychiatry; 2010 Feb; 25(2):202-7. PubMed ID: 19513990 [TBL] [Abstract][Full Text] [Related]
3. Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome. Coppus AM; Schuur M; Vergeer J; Janssens AC; Oostra BA; Verbeek MM; van Duijn CM Neurobiol Aging; 2012 Sep; 33(9):1988-94. PubMed ID: 21958962 [TBL] [Abstract][Full Text] [Related]
12. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia. Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361 [TBL] [Abstract][Full Text] [Related]
13. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN; Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease. Lövheim H; Elgh F; Johansson A; Zetterberg H; Blennow K; Hallmans G; Eriksson S Alzheimers Dement; 2017 Jul; 13(7):778-782. PubMed ID: 28073031 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of plasma amyloid-β levels in Alzheimer's disease. Song F; Poljak A; Valenzuela M; Mayeux R; Smythe GA; Sachdev PS J Alzheimers Dis; 2011; 26(2):365-75. PubMed ID: 21709378 [TBL] [Abstract][Full Text] [Related]
16. The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease. Hsu JL; Lee WJ; Liao YC; Wang SJ; Fuh JL Alzheimers Res Ther; 2017 Nov; 9(1):91. PubMed ID: 29169407 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study. Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816 [TBL] [Abstract][Full Text] [Related]
18. Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study. Kaffashian S; Tzourio C; Soumaré A; Dufouil C; Mazoyer B; Schraen-Maschke S; Buée L; Debette S Neurobiol Aging; 2015 Oct; 36(10):2663-70. PubMed ID: 26242707 [TBL] [Abstract][Full Text] [Related]
19. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment. Fei M; Jianghua W; Rujuan M; Wei Z; Qian W J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911 [TBL] [Abstract][Full Text] [Related]
20. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]